Adage Capital Partners Gp, L.L.C. Regeneron Pharmaceuticals, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 95,630 shares of REGN stock, worth $55.8 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
95,630
Previous 92,745
3.11%
Holding current value
$55.8 Million
Previous $58.8 Million
14.65%
% of portfolio
0.09%
Previous 0.11%
Shares
27 transactions
Others Institutions Holding REGN
# of Institutions
1,420Shares Held
88.7MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.5 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.93 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.3 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.82 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.23 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $62.5B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...